(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are Giga, Sirius XM Holdings, and Aspen Group.

The three biggest losers today are Republic First Bancorp, Globus Maritime Limited, and Xenetic Biosciences.

Winners today

1. Giga (GIGA) – 15.38%

Giga-tronics Incorporated, together with its subsidiaries, develops and manufactures electronics equipment for military test and airborne operational applications in the United States and internationally. It operates through two segments, Microsource and the Giga-tronics Division. The company develops microwave components; Band Reject Filters for RADAR/EW (electronic warfare) for solving interference problems in RADAR/EW applications, as well as low noise oscillators used in shipboard and land-based self-protection systems; and RADAR filters for military fighter jet aircraft. It also designs, manufactures, and markets functional test systems for the RADAR/EW equipment of the defense electronics market. The company serves prime defense contractors, the armed services, and research institutes. Giga-tronics Incorporated was incorporated in 1980 and is headquartered in Dublin, California.

NASDAQ ended the session with Giga jumping 15.38% to $0.12 on Thursday while NASDAQ jumped 0.83% to $13,201.28.

Earnings Per Share

As for profitability, Giga has a trailing twelve months EPS of $-2.79.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -153.4%.

Moving Average

Giga’s value is way under its 50-day moving average of $0.25 and way below its 200-day moving average of $0.50.

Volume

Today’s last reported volume for Giga is 3230 which is 43.7% below its average volume of 5738.

Revenue Growth

Year-on-year quarterly revenue growth grew by 35%, now sitting on 34.01M for the twelve trailing months.

Yearly Top and Bottom Value

Giga’s stock is valued at $0.12 at 17:32 EST, way below its 52-week high of $2.39 and way higher than its 52-week low of $0.09.

More news about Giga.

2. Sirius XM Holdings (SIRI) – 13.88%

Sirius XM Holdings Inc., an audio entertainment company, operates audio business including subscription entertainment services in the United States. It operates through Sirius XM, and Pandora and Off-platform segment. The company's Sirius XM segment provides music, sports, entertainment, comedy, news, traffic and weather channels, and other content, as well as podcast and infotainment services on subscription fee basis; and live, curated, and exclusive and on demand programming services through satellite radio system and streamed via applications for mobile and home devices, and other consumer electronic equipment. Its Pandora and Off-platform segment operates music and podcast streaming platform, which offers personalized experience for listener through computers, tablets, mobile devices, vehicle speakers, and connected devices. In addition, the company offers podcasts including true crime to politics, sports, comedy, and other podcasts under Stitcher brand. Further, it distributes satellite radios through automakers and retailers, as well as its website. The company also provides location-based services through two-way wireless connectivity, including safety, security, convenience, remote vehicles diagnostic, maintenance and data, and stolen or parked vehicle locator services. Additionally, it offers satellite television services, which offer music channels on the DISH Network satellite television service as a programming package; Travel Link, a suite of data services that include graphical weather, fuel prices, sports schedule and scores, and movie listings; and real-time traffic and weather services, as well as music programming and commercial-free music services for commercial, office, restaurants, and other business. The company was incorporated in 2013 and is headquartered in New York. Sirius XM Holdings Inc. is a subsidiary of Liberty Media Corporation.

NASDAQ ended the session with Sirius XM Holdings rising 13.88% to $4.64 on Thursday, following the last session’s upward trend. NASDAQ rose 0.83% to $13,201.28, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, Sirius XM Holdings has a trailing twelve months EPS of $0.3.

PE Ratio

Sirius XM Holdings has a trailing twelve months price to earnings ratio of 15.45. Meaning, the purchaser of the share is investing $15.45 for every dollar of annual earnings.

Growth Estimates Quarters

The company’s growth estimates for the present quarter is 33.3% and a drop 11.1% for the next.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Sirius XM Holdings’s stock is considered to be overbought (>=80).

More news about Sirius XM Holdings.

3. Aspen Group (ASPU) – 10.99%

Aspen Group, Inc., an education technology company, provides online higher education services in the United States. The company offers baccalaureate, master's, and doctoral degree programs in nursing and health sciences, business and technology, arts and sciences, and education fields through Aspen University and United States University. As of April 30, 2022, it had 13,334 degree-seeking students enrolled. Aspen Group, Inc. was founded in 1987 and is based in New York, New York.

NASDAQ ended the session with Aspen Group rising 10.99% to $0.18 on Thursday while NASDAQ rose 0.83% to $13,201.28.

Earnings Per Share

As for profitability, Aspen Group has a trailing twelve months EPS of $-0.36.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.26%.

More news about Aspen Group.

4. Hallmark Financial Services (HALL) – 9.84%

Hallmark Financial Services, Inc. underwrites, markets, distributes, and services property/casualty insurance products to businesses and individuals in the United States. The company operates through Specialty Commercial, Standard Commercial, and Personal segments. The Specialty Commercial segment offers primary and excess commercial vehicle insurance products and services; primary and excess liability, excess public entity liability, and E&S package and garage liability insurance products and services; primary and excess commercial property insurance for catastrophe and non-catastrophe exposures; healthcare and financial lines professional liability insurance products and services primarily for businesses, medical professionals, medical facilities, and senior care facilities; and satellite launch property/casualty insurance products and services, as well as various specialty programs. The Standard Commercial segment provides package and monoline property/casualty insurance products and services. The Personal segment offers non-standard personal automobile and renters insurance products and services. It markets its insurance products through independent general agents, retail agents, and specialty brokers. The company was incorporated in 1987 and is headquartered in Dallas, Texas.

NASDAQ ended the session with Hallmark Financial Services rising 9.84% to $2.12 on Thursday, following the last session’s downward trend. NASDAQ jumped 0.83% to $13,201.28, following the last session’s upward trend on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, Hallmark Financial Services has a trailing twelve months EPS of $-63.03.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -208.26%.

Volume

Today’s last reported volume for Hallmark Financial Services is 1092 which is 89.56% below its average volume of 10468.

Moving Average

Hallmark Financial Services’s value is way below its 50-day moving average of $3.24 and way under its 200-day moving average of $5.63.

More news about Hallmark Financial Services.

5. Fuel Tech (FTEK) – 9.07%

Fuel Tech, Inc. provides boiler optimization, efficiency improvement, and air pollution reduction and control solutions to utility and industrial customers worldwide. It operates through two segments, Air Pollution Control Technology and FUEL CHEM Technology. The Air Pollution Control Technology segment offers technologies to reduce nitrogen oxide (NOx) emissions in flue gas from boilers, incinerators, furnaces, and other stationary combustion sources by low and ultra-low NOx burners; over-fire air systems; NOxOUT and HERT selective non-catalytic reduction systems; selective catalytic reduction systems comprising ammonia injection grid, and graduated straightening grid systems; I-NOx systems; ESP Processes and Services; ULTRA technology; and flue gas conditioning systems; and burner systems. The FUEL CHEM Technology segment provides programs to improve the efficiency, reliability, fuel flexibility, boiler heat rate, and environmental status of combustion units by controlling slagging, fouling, corrosion, opacity, and acid plume, as well as the formation of sulfur trioxide, ammonium bisulfate, particulate matter, sulfur dioxide, and carbon dioxide through the addition of chemicals into the furnace using TIFI targeted in-furnace injection technology. This segment offers its FUEL CHEM program for plants operating in the electric utility, industrial, pulp and paper, waste-to-energy, and university and district heating markets; and the owners of boilers, furnaces, and other combustion units. The company was incorporated in 1987 and is headquartered in Warrenville, Illinois.

NASDAQ ended the session with Fuel Tech jumping 9.07% to $1.08 on Thursday, following the last session’s upward trend. NASDAQ rose 0.83% to $13,201.28, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, Fuel Tech has a trailing twelve months EPS of $-0.05.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -3.5%.

Yearly Top and Bottom Value

Fuel Tech’s stock is valued at $1.08 at 17:32 EST, way below its 52-week high of $1.83 and above its 52-week low of $0.99.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Fuel Tech’s EBITDA is 0.19.

Volume

Today’s last reported volume for Fuel Tech is 236056 which is 276.77% above its average volume of 62652.

Moving Average

Fuel Tech’s worth is under its 50-day moving average of $1.17 and way under its 200-day moving average of $1.32.

More news about Fuel Tech.

6. Electro-Sensors (ELSE) – 7.92%

Electro-Sensors, Inc. engages in the manufacture and sale of industrial production monitoring and process control systems. The company manufactures and sells various monitoring and control systems that measure machine production and operation rates, as well as regulate the speed of related machines in production processes. Its speed monitoring systems include a line of products that measure production counts or rates, such as parts, gallons, or board feet; and alarm systems, tachometers, and other devices that translate impulses from the sensors into alarm signals, computer inputs, or digital displays. The company's temperature application products consist of bearing, gear box, and motor temperature monitoring sensors. It also offers production monitoring devices that include a belt alignment and slide gate position monitors; vibration monitoring products; and tilt switches. In addition, the company provides hazard monitoring systems, such as Electro-Sentry, which integrates its sensors for monitoring temperature, belt alignment, and shaft speed with programmable control logic; HazardPRO, a wireless hazard technology monitoring system; and HazardPRO site system manager software. It serves grain/feed/milling, bulk material, manufacturing, food product, ethanol, power generation, and other processing industries. The company sells its products through internal sales team, manufacturer's representatives, and distributors in the United States, Canada, Mexico, Brazil, Chile, Guatemala, Germany, Peru, United Kingdom, Ukraine, Egypt, Saudi Arabia, the United Arab Emirates, South Africa, Tunisia, India, Australia, China, the Republic of Korea, Vietnam, Malaysia, the Philippines, Thailand, and Singapore. Electro-Sensors, Inc. was incorporated in 1968 and is headquartered in Minnetonka, Minnesota.

NASDAQ ended the session with Electro-Sensors rising 7.92% to $4.09 on Thursday while NASDAQ jumped 0.83% to $13,201.28.

Earnings Per Share

As for profitability, Electro-Sensors has a trailing twelve months EPS of $0.14.

PE Ratio

Electro-Sensors has a trailing twelve months price to earnings ratio of 29.21. Meaning, the purchaser of the share is investing $29.21 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.53%.

More news about Electro-Sensors.

7. Marathon (MARA) – 7.62%

Marathon Digital Holdings, Inc. operates as a digital asset technology company that mines digital assets with a focus on the blockchain ecosystem and the generation of digital assets in United States. The company was formerly known as Marathon Patent Group, Inc. and changed its name to Marathon Digital Holdings, Inc. in February 2021. Marathon Digital Holdings, Inc. was incorporated in 2010 and is headquartered in Fort Lauderdale, Florida.

NASDAQ ended the session with Marathon rising 7.62% to $8.62 on Thursday while NASDAQ jumped 0.83% to $13,201.28.

Earnings Per Share

As for profitability, Marathon has a trailing twelve months EPS of $-3.9.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -76.14%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Marathon’s EBITDA is 14.62.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 81.5% and 96.2%, respectively.

Yearly Top and Bottom Value

Marathon’s stock is valued at $8.62 at 17:32 EST, way under its 52-week high of $19.88 and way above its 52-week low of $3.11.

Revenue Growth

Year-on-year quarterly revenue growth grew by 228%, now sitting on 174M for the twelve trailing months.

Previous days news about Marathon

• Marathon oil (mro) stock moves -1.2%: what you should know. According to Zacks on Tuesday, 26 September, "In the latest trading session, Marathon Oil (MRO Quick QuoteMRO – Free Report) closed at $26.29, marking a -1.2% move from the previous day. ", "Investors will be hoping for strength from Marathon Oil as it approaches its next earnings release. "

More news about Marathon.

8. Trimble (TRMB) – 7.11%

Trimble Inc. provides technology solutions that enable professionals and field mobile workers to enhance or transform their work processes worldwide. The company's Buildings and Infrastructure segment offers field and office software for route selection and design; systems to guide and control construction equipment; software for 3D design and data sharing; systems to monitor, track, and manage assets, equipment, and workers; software to share and communicate data; program management solutions for construction owners; 3D conceptual design and modeling software; building information modeling software; enterprise resource planning, project management, and project collaboration solutions; integrated site layout and measurement systems; cost estimating, scheduling, and project controls solutions; and applications for sub-contractors and trades. Its Geospatial segment provides surveying and geospatial products, and geographic information systems. The company's Resources and Utilities segment offers precision agriculture products and services, such as guidance and positioning systems, including autonomous steering systems, automated and variable-rate application and technology systems, and information management solutions; manual and automated navigation guidance for tractors and other farm equipment; solutions to automate application of pesticide and seeding; water solutions; and agricultural software. Its Transportation segment offers solutions for long haul trucking and freight shipper markets; mobility solutions comprising route management, safety and compliance, end-to-end vehicle management, video intelligence, and supply chain communications; and fleet and transportation management systems, analytics, routing, mapping, reporting, and predictive modeling solutions. The company was formerly known as Trimble Navigation Limited and changed its name to Trimble Inc. in October 2016. Trimble Inc. was founded in 1978 and is headquartered in Westminster, Colorado.

NASDAQ ended the session with Trimble rising 7.11% to $52.71 on Thursday, following the last session’s upward trend. NASDAQ rose 0.83% to $13,201.28, following the last session’s upward trend on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, Trimble has a trailing twelve months EPS of $1.36.

PE Ratio

Trimble has a trailing twelve months price to earnings ratio of 38.76. Meaning, the purchaser of the share is investing $38.76 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.38%.

Volume

Today’s last reported volume for Trimble is 1409260 which is 19.57% above its average volume of 1178510.

Previous days news about Trimble

• Trimble (trmb) boosts geospatial segment with new partnership. According to Zacks on Wednesday, 27 September, "The receiver uses Trimble Maxwell 7 chipset technology for fast processing, anti-spoofing and GNSS constellation tracking, enhancing satellite availability and robust positioning in diverse environments.", "Additionally, the network will utilize Trimble Pivot Platform software for managing CORS stations and generating accurate GNSS corrections, ensuring a reliable, efficient workflow for both operators and end users."

More news about Trimble.

9. Geospace Technologies Corporation (GEOS) – 7.09%

Geospace Technologies Corporation designs and manufactures instruments and equipment used in the oil and gas industry to acquire seismic data in order to locate, characterize, and monitor hydrocarbon producing reservoirs. The company operates through three segments: Oil and Gas Markets, Adjacent Markets, and Emerging Markets. The Oil and Gas Markets segment offers wireless seismic data acquisition systems and reservoir characterization products and services, as well as traditional seismic exploration products, such as geophones, hydrophones, leader wires, connectors, cables, marine streamer retrieval and steering devices, and other seismic products. The Adjacent Markets segment provides industrial products, including imaging equipment, water meter products, remote shut-off valves and Internet of Things platform, and offshore cables, as well as seismic sensors for vibration monitoring and geotechnical applications, such as mine safety and earthquake detection applications; and electronic pre-press products that employ direct thermal imaging, direct-to-screen printing systems, and digital inkjet printing technologies targeted at the commercial and industrial graphics, textile, and flexographic printing industries. The Emerging Markets segment designs and sells products used for border and perimeter security surveillance, cross-border tunneling detection, and other products targeted at movement monitoring, intrusion detection, and situational awareness. This segment serves customers that include various agencies of the United States government, including the Department of Defense, Department of Energy, Department of Homeland Security, and other agencies. The company operates in Asia, Canada, Europe, the United States, and internationally. Geospace Technologies Corporation was founded in 1980 and is headquartered in Houston, Texas.

NASDAQ ended the session with Geospace Technologies Corporation rising 7.09% to $13.74 on Thursday while NASDAQ jumped 0.83% to $13,201.28.

Earnings Per Share

As for profitability, Geospace Technologies Corporation has a trailing twelve months EPS of $-0.03.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -0.21%.

More news about Geospace Technologies Corporation.

10. Palantir (PLTR) – 6.77%

Palantir Technologies Inc. builds and deploys software platforms for the intelligence community in the United States to assist in counterterrorism investigations and operations. The company provides Palantir Gotham, a software platform which enables users to identify patterns hidden deep within datasets, ranging from signals intelligence sources to reports from confidential informants, as well as facilitates the handoff between analysts and operational users, helping operators plan and execute real-world responses to threats that have been identified within the platform. It also offers Palantir Foundry, a platform that transforms the ways organizations operate by creating a central operating system for their data; and allows individual users to integrate and analyze the data they need in one place. In addition, it provides Palantir Apollo, a software that enables customers to deploy their own software virtually in any environment. Palantir Technologies Inc. was incorporated in 2003 and is based in Denver, Colorado.

NYSE ended the session with Palantir jumping 6.77% to $15.85 on Thursday, after two sequential sessions in a row of gains. NYSE jumped 0.54% to $15,478.07, following the last session’s upward trend on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, Palantir has a trailing twelve months EPS of $-0.02.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -9.7%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 17.7%, now sitting on 1.98B for the twelve trailing months.

Previous days news about Palantir

• Palantir stock forecast: PLTR advances following $250 million army contract. According to FXStreet on Wednesday, 27 September, "Still, Palantir has been rolling out its Artificial Intelligence Platform (AIP) at a quick pace so far in the third quarter. ", "Early Wednesday, the Army Contracting Command attached to the Aberdeen Proving Ground in Maryland approved Palantir for a $250 million contract to provide research related to AI and machine learning."

More news about Palantir.

Losers Today

1. Republic First Bancorp (FRBK) – -39.29%

Republic First Bancorp, Inc. operates as the holding company for Republic First Bank that provides a range of credit and depository banking products and services to individuals and businesses. It accepts consumer and commercial deposit, checking, interest-bearing demand, money market, savings, sweep, and individual retirement accounts, as well as certificates of deposit. The company also offers secured and unsecured commercial, real estate, construction and land development, automobile, and home improvement loans; mortgages, home equity and overdraft lines of credit, and other products; and lockbox services. As of April 5, 2022, it operated 34 offices located in Atlantic, Burlington, Camden, and Gloucester counties in New Jersey; Bucks, Delaware, Montgomery, and Philadelphia counties in Pennsylvania; and New York County in New York. Republic First Bancorp, Inc. was founded in 1987 and is based in Philadelphia, Pennsylvania.

NASDAQ ended the session with Republic First Bancorp sliding 39.29% to $0.17 on Thursday while NASDAQ rose 0.83% to $13,201.28.

Earnings Per Share

As for profitability, Republic First Bancorp has a trailing twelve months EPS of $0.22.

PE Ratio

Republic First Bancorp has a trailing twelve months price to earnings ratio of 0.77. Meaning, the purchaser of the share is investing $0.77 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.96%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 37.7%, now sitting on 164.07M for the twelve trailing months.

More news about Republic First Bancorp.

2. Globus Maritime Limited (GLBS) – -15.17%

Globus Maritime Limited, an integrated dry bulk shipping company, provides marine transportation services worldwide. It owns, operates, and manages a fleet of dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina, and other dry bulk cargoes. As of March 31, 2022, the company's fleet included nine vessels with a total carrying capacity of 626,257 deadweight tonnage. It charters its vessels to operators, trading houses, shipping companies and producers, and government-owned entities. The company was incorporated in 2006 and is based in Athens, Greece. Globus Maritime Limited is a subsidiary of Firment Trading Limited.

NASDAQ ended the session with Globus Maritime Limited dropping 15.17% to $1.51 on Thursday while NASDAQ jumped 0.83% to $13,201.28.

Earnings Per Share

As for profitability, Globus Maritime Limited has a trailing twelve months EPS of $0.13.

PE Ratio

Globus Maritime Limited has a trailing twelve months price to earnings ratio of 11.62. Meaning, the purchaser of the share is investing $11.62 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.53%.

Yearly Top and Bottom Value

Globus Maritime Limited’s stock is valued at $1.51 at 17:32 EST, way below its 52-week high of $1.79 and way higher than its 52-week low of $0.68.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Globus Maritime Limited’s EBITDA is 0.39.

Revenue Growth

Year-on-year quarterly revenue growth declined by 59.1%, now sitting on 40.59M for the twelve trailing months.

More news about Globus Maritime Limited.

3. Xenetic Biosciences (XBIO) – -10.36%

Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the development of biologic drugs and therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. In addition, the company leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, and PJSC Pharmsynthez. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.

NASDAQ ended the session with Xenetic Biosciences falling 10.36% to $5.05 on Thursday while NASDAQ rose 0.83% to $13,201.28.

Earnings Per Share

As for profitability, Xenetic Biosciences has a trailing twelve months EPS of $-2.77.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -30.99%.

More news about Xenetic Biosciences.

4. CarMax (KMX) – -9.96%

CarMax, Inc., together with its subsidiaries, operates as a retailer of used vehicles in the United States. It operates in two segments, CarMax Sales Operations and CarMax Auto Finance. The company offers customers a range of makes and models of used vehicles, including domestic, imported, and luxury vehicles, as well as hybrid and electric vehicles; and extended protection plans to customers at the time of sale, as well as sells vehicles that are approximately 10 years old and has more than 100,000 miles through wholesale auctions. It also provides reconditioning and vehicle repair services; and financing alternatives for retail customers across a range of credit spectrum through its CarMax Auto Finance and arrangements with various financial institutions. The company was founded in 1993 and is based in Richmond, Virginia.

NYSE ended the session with CarMax falling 9.96% to $71.75 on Thursday, after three consecutive sessions in a row of gains. NYSE rose 0.54% to $15,478.07, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.

Carmax (kmx) Q2 earnings meet estimatesWhile CarMax has outperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?

Carmax (kmx) reports Q2 earnings: what key metrics have to sayHere is how CarMax performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Earnings Per Share

As for profitability, CarMax has a trailing twelve months EPS of $2.93.

PE Ratio

CarMax has a trailing twelve months price to earnings ratio of 24.49. Meaning, the purchaser of the share is investing $24.49 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.21%.

More news about CarMax.

5. Amicus Therapeutics (FOLD) – -9.82%

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. The company also develops AT-GAA, a novel treatment paradigm for Pompe disease; and enzyme replacement therapies for Pompe diseases. It has collaboration and license agreements with Nationwide Children's Hospital; University of Pennsylvania; and GlaxoSmithKline. The company was incorporated in 2002 and is headquartered in Philadelphia, Pennsylvania.

NASDAQ ended the session with Amicus Therapeutics sliding 9.82% to $11.61 on Thursday, after two sequential sessions in a row of gains. NASDAQ rose 0.83% to $13,201.28, following the last session’s upward trend on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, Amicus Therapeutics has a trailing twelve months EPS of $-0.67.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -130.04%.

More news about Amicus Therapeutics.

6. Aurora Cannabis (ACB) – -9.34%

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Leduc, Canada.

NYSE ended the session with Aurora Cannabis dropping 9.34% to $0.60 on Thursday while NYSE rose 0.54% to $15,478.07.

: aurora cannabis selling stock to pay down debtAlberta-based Aurora Cannabis Inc. said Thursday it agreed to sell up to 53.19 million common shares to Canaccord Genuity at a price of C$0.73 per offered security for proceeds of up to about C$38.83 million ($28.78 million).

Earnings Per Share

As for profitability, Aurora Cannabis has a trailing twelve months EPS of $-5.5.

More news about Aurora Cannabis.

7. Workday (WDAY) – -9.02%

Workday, Inc. provides enterprise cloud applications in the United States and internationally. Its applications help its customers to plan, execute, analyze, and extend to other applications and environments, and to manage their business and operations. The company offers a suite of financial management applications, which enable chief financial officers to maintain accounting information in the general ledger; manage financial processes, such as payables and receivables; identify real-time financial, operational, and management insights; enhance financial consolidation; reduce time-to-close; promote internal control and auditability; and achieve consistency across finance operations. It also provides spend management solutions that helps organizations to streamline supplier selection and contracts, manage indirect spend, and build and execute sourcing events, such as requests for proposals; and human capital management solution, a suite of human capital management applications that allows organizations to manage the entire employee lifecycle from recruitment to retirement, and enables HR teams to hire, onboard, pay, develop, reskill, and provide employee experiences. In addition, the company offers applications for planning; and applications for analytics and reporting comprising augmented analytics to surface insights to the line of business in simple-to-understand stories, machine learning to drive efficiency and automation, and benchmarks to compare performance against other companies. It serves professional and business services, financial services, healthcare, education, government, technology, media, retail, and hospitality industries. The company has a partnership with Accenture to develop a suite of data-led and composable finance solutions. The company was formerly known as North Tahoe Power Tools, Inc. and changed its name to Workday, Inc. in July 2005. Workday, Inc. was incorporated in 2005 and is headquartered in Pleasanton, California.

NASDAQ ended the session with Workday sliding 9.02% to $209.99 on Thursday while NASDAQ rose 0.83% to $13,201.28.

Earnings Per Share

As for profitability, Workday has a trailing twelve months EPS of $-0.48.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -2.13%.

More news about Workday.

8. Galmed Pharmaceuticals Ltd. (GLMD) – -8.77%

Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinical trial with HIV-associated non-alcoholic fatty liver disease and lipodystrophy. In addition, it engages in the development of Amilo-5MER, a 5 amino acid synthetic peptide methionine, threonine, alanine, aspartic acid, and valine. It has a research agreement with Gannex Pharma Co., Ltd. to develop a combination therapy of ASC41 (THR-beta agonist) and Aramchol (SCD 1 inhibitor) for the treatment of NASH; a research and development collaboration agreement with MyBiotics Pharma Ltd. to identify the selected microbiome repertoire associated with the response to Aramchol; and a license agreement with Samil Pharma. Co., Ltd. for the commercialization of Aramchol in the Republic of Korea. Galmed Pharmaceuticals Ltd. was founded in 2000 and is headquartered in Tel Aviv, Israel.

NASDAQ ended the session with Galmed Pharmaceuticals Ltd. sliding 8.77% to $0.54 on Thursday while NASDAQ rose 0.83% to $13,201.28.

Earnings Per Share

As for profitability, Galmed Pharmaceuticals Ltd. has a trailing twelve months EPS of $-6.24.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -73%.

More news about Galmed Pharmaceuticals Ltd..

9. Canopy Growth (CGC) – -7.92%

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

NASDAQ ended the session with Canopy Growth sliding 7.92% to $0.82 on Thursday, after four sequential sessions in a row of losses. NASDAQ jumped 0.83% to $13,201.28, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, Canopy Growth has a trailing twelve months EPS of $-1.55.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -99.56%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 2.6%, now sitting on 405.71M for the twelve trailing months.

More news about Canopy Growth.

10. Esperion Therapeutics (ESPR) – -6.1%

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.

NASDAQ ended the session with Esperion Therapeutics dropping 6.1% to $0.99 on Thursday while NASDAQ jumped 0.83% to $13,201.28.

Earnings Per Share

As for profitability, Esperion Therapeutics has a trailing twelve months EPS of $-2.89.

Volume

Today’s last reported volume for Esperion Therapeutics is 4422880 which is 28.15% above its average volume of 3451270.

More news about Esperion Therapeutics.

Stay up to date with our winners and losers daily report